"Ranger BTK" a Prospective Single-Centre Cohort Study on a New Drug-Coated Balloon for Below the Knee Lesions in Patients with Critical Limb Ischemia.
Costantino Del GiudiceAlexandre GalloulaClarisse TiercelinAurélie VilfaillotJean Marc AlsacEmmanuel MessasCarole L DéanEtienne LargerMarc SapovalPublished in: Cardiovascular and interventional radiology (2021)
Ranger DCB balloons to treat CLI patients demonstrated a positive trend with good safety outcomes parameters. Further randomized studies are needed to understand the usefulness compared to POBA.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- total knee arthroplasty
- open label
- double blind
- prognostic factors
- peritoneal dialysis
- tyrosine kinase
- emergency department
- placebo controlled
- knee osteoarthritis
- metabolic syndrome
- phase ii
- clinical trial
- patient reported outcomes
- skeletal muscle
- phase iii
- patient reported